Protagenic Therapeutics, Inc. (PTIX)
1.026
-0.03
(-3.22%)
USD |
OTCM |
Sep 08, 16:00
Protagenic Therapeutics Enterprise Value : 1.291M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 1.291M |
| September 04, 2026 | 1.353M |
| September 03, 2026 | 1.244M |
| September 02, 2026 | 1.335M |
| September 01, 2026 | 1.588M |
| August 31, 2026 | 1.606M |
| August 28, 2026 | 1.208M |
| August 27, 2026 | 1.127M |
| August 26, 2026 | 1.045M |
| August 25, 2026 | 1.154M |
| August 24, 2026 | 1.407M |
| August 21, 2026 | 0.8842M |
| August 20, 2026 | 0.5201M |
| August 19, 2026 | 0.0676M |
| August 18, 2026 | 0.0857M |
| August 17, 2026 | 0.0857M |
| August 14, 2026 | 0.0857M |
| August 13, 2026 | 0.0857M |
| August 12, 2026 | 0.0857M |
| August 11, 2026 | 0.0133M |
| August 10, 2026 | 0.0676M |
| August 07, 2026 | -0.0057M |
| August 06, 2026 | -0.1678M |
| August 05, 2026 | -0.0975M |
| August 04, 2026 | -0.1859M |
| Date | Value |
|---|---|
| August 03, 2026 | -0.2341M |
| July 31, 2026 | -0.2402M |
| July 30, 2026 | -0.2644M |
| July 29, 2026 | -0.3339M |
| July 28, 2026 | -0.3126M |
| July 27, 2026 | -0.1688M |
| July 24, 2026 | -0.1757M |
| July 23, 2026 | -0.1757M |
| July 22, 2026 | -0.1757M |
| July 21, 2026 | -0.1757M |
| July 20, 2026 | -0.0948M |
| July 17, 2026 | -0.0948M |
| July 16, 2026 | -0.0948M |
| July 15, 2026 | -0.0948M |
| July 14, 2026 | -0.0948M |
| July 13, 2026 | -0.0948M |
| July 10, 2026 | -0.0953M |
| July 09, 2026 | -0.1678M |
| July 08, 2026 | -0.2221M |
| July 07, 2026 | -0.204M |
| July 06, 2026 | -0.1643M |
| July 02, 2026 | -0.1497M |
| July 01, 2026 | 0.0676M |
| June 30, 2026 | 0.1438M |
| June 29, 2026 | -0.7994M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 11.79B |
| Oncolytics Biotech, Inc. | 96.67M |
| Sangamo Therapeutics, Inc. | 58.40M |
| Sarepta Therapeutics, Inc. | 2.469B |
| Anixa Biosciences, Inc. | 83.62M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.9636M |
| Total Expenses (Quarterly) | 0.9636M |
| EPS Diluted (Quarterly) | -0.5323 |
| Earnings Yield | 287.4% |
| Normalized Earnings Yield | 200.52 |